Piramal to expand Aurora facility with API manufacturing wing
(from left to right) Tom Mrakas - Aurora Town Mayor, Peter DeYoung, CEO Piramal Pharma Solutions and Wen-Lung Yeh, President, Piramal Pharma Solutions (Canada)
Indian CDMO Piramal Pharma Solutions said Tuesday it will invest C$25 million to expand the capacity of its Aurora facility in Canada by 10,500 square feet to house a new wing for manufacturing active pharmaceutical ingredients (APIs).
“This additional capacity will help us to strengthen our presence in Canada as well as service other geographies such as North America and Europe, whilst enabling us to support our customer’s API requirements and market demand for integrated solutions,” said Peter DeYoung, CEO, Piramal Pharma Solutions.
Piramal said the additional capacity will cater to increasing customer demand as well as support the facility’s ability to provide APIs and HPAPIs down to an Occupational Exposure Limit (OEL) of 1mcg/m3.
Apart from the existing production scale reactors, the expansion will include two new reactor suites as well as a dedicated filter dryer room and a portable filter dryer.
The expansion is expected to be completed and running by the end of April 2021.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance